Home » Topics » BioWorld Science, Cardiovascular

BioWorld Science, Cardiovascular
RSS

Karos reports phase I outcomes for KAR-5585

Aug. 18, 2016

Merck & Co. patents potassium channel blockers

Aug. 16, 2016

MedImmune develops TB4 fusion polypeptides

Aug. 12, 2016

Resverlogix will continue phase III trial testing apabetalone based on DSMB recommendation

Aug. 12, 2016

Pluristem Therapeutics' critical limb ischemia program awarded USD 8 million

Aug. 10, 2016

MyoKardia presents cardiac myosin activators

Aug. 8, 2016

ScinoPharm and CVie Therapeutics collaborate to develop new heart failure drug

Aug. 5, 2016

Genetic variant in BMAL1 is associated with higher risk of CVD

Aug. 2, 2016

Bayer Healthcare patents chemokine receptor antagonists

Aug. 2, 2016

Increased p-cresyl sulfate level is independent predictor of poor outcome in heart failure

Aug. 1, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 9, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...